Product image of Niquitin Minitab Citrusízű (Nicotine) supplied by GNH India

Niquitin Minitab Citrusízű

Active Ingredient:
Nicotine
Origin:
EU

Niquitin Minitab Citrusízű (Nicotine)

Nicotine, the active ingredient in Niquitin Minitab Citrusízű, is a nicotine drug class presented as an unspecified strength/oromucosal form for oromucosal use. It is intended to aid smoking cessation in adult tobacco users. By reducing cravings and withdrawal symptoms, it supports the quitting process.

GNH India supplies Niquitin Minitab Citrusízű as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for cross‑border procurement. Customers benefit from reliable lead times and dedicated technical support throughout the supply chain.

Manufacturer / TM Owner

Omega Pharma Hungary Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nicotine is used in smoking cessation therapy to address nicotine dependence and related withdrawal.

  • Smoking cessation: helps adult smokers quit by delivering controlled nicotine to reduce cravings.
  • Tobacco dependence: supports reduction of daily tobacco intake during a quit attempt.
  • Nicotine withdrawal: alleviates symptoms such as irritability, anxiety, and difficulty concentrating.

How It Works

  • Nicotine acts as an agonist at nicotinic acetylcholine receptors (nAChRs) in the central and peripheral nervous systems. Stimulation of these receptors mimics the pharmacologic effects of tobacco‑derived nicotine, thereby decreasing the intensity of withdrawal symptoms and cravings. The oromucosal delivery enables rapid absorption through the oral mucosa, achieving plasma concentrations that satisfy brain receptors while allowing gradual tapering.

Side Effects

Nicotine replacement products can cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Mouth irritation: soreness or tingling of the oral mucosa.
  • Nausea: feeling of stomach upset after use.
  • Throat irritation: scratchy sensation in the throat.
  • Dizziness: light‑headed feeling, especially when standing quickly.

Serious or Rare Side Effects

  • Hypertension: elevated blood pressure requiring medical attention.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Seizures: rare neurologic event associated with high nicotine exposure.

Precautions & Warnings

When using nicotine oral mucosal products, several safety considerations apply.

  • Pregnancy: consult a healthcare professional before use, as safety data are limited.
  • Breastfeeding: consider potential nicotine exposure to the infant; seek medical advice.
  • Cardiovascular disease: monitor blood pressure and heart rate during therapy.
  • Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously.
  • Children and adolescents: not recommended for individuals under 18 years of age.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nicotine may interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may cause excessive hypertensive response.
  • Insulin or oral hypoglycemics: nicotine can affect glucose control, requiring dose adjustment.
  • Theophylline: nicotine may increase plasma theophylline concentrations.

Moderate Interactions (Monitor Closely)

  • CYP2A6 inhibitors (e.g., methoxsalen): can reduce nicotine metabolism, increasing exposure.
  • Antidepressants (SSRIs, SNRIs): may enhance nicotine‑related side effects such as nausea.
  • Antihypertensive agents: nicotine may diminish their efficacy, necessitating blood pressure monitoring.

Frequently Asked Questions

Niquitin Minitab Citrusízű is an oromucosal nicotine product intended to help adult smokers quit tobacco. It delivers a controlled amount of nicotine to reduce cravings and withdrawal symptoms, supporting a structured smoking‑cessation program.

The nicotine in Niquitin Minitab Citrusízű binds to nicotinic acetylcholine receptors in the brain, producing a mild stimulant effect that mimics the action of tobacco‑derived nicotine. This reduces the intensity of withdrawal and the urge to smoke while the user tapers the dose.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for nicotine replacement products in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with nicotine patches or gum, the oromucosal form of Niquitin Minitab Citrusízű offers rapid absorption through the oral mucosa, providing quicker symptom relief. It may be preferred by patients who find patches inconvenient or who experience gum irritation, while still delivering a controlled nicotine dose.

Store Niquitin Minitab Citrusízű at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The product is placed in the mouth and allowed to dissolve or be absorbed through the oral mucosa as directed by the prescriber. It should not be swallowed whole; instead, allow the dosage form to remain in contact with the mucosal surface for optimal absorption.

Serious risks include hypertension, severe allergic reactions (such as rash, swelling, or breathing difficulty), and rare neurologic events like seizures. Patients experiencing any of these symptoms should seek immediate medical attention.

The product is not recommended for individuals under 18 years of age, for patients with uncontrolled cardiovascular disease, for those taking monoamine oxidase inhibitors, or for anyone who is allergic to nicotine or any excipients in the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT